Skip to main content
. 2015 May 7;6(24):20204–20214. doi: 10.18632/oncotarget.3887

Table 2. Associations between CD204+ST Mφ density and the clinicopathological characteristics of UCB.

CD204+ST Mφ Density
Variable Low High R P
No. of patients 151 (50%) 151 (50%)
Age, years 0.086 0.135
 ≤60 85 (28%) 72 (24%)
 >60 66 (22%) 79 (26%)
Gender 0.039 0.499
 Male 133 (44%) 129 (43%)
 Female 18 (6%) 22 (7%)
Tumor size 0.183 0.001
 ≤3 cm 129 (43%) 106 (35%)
 >3 cm 22 (7%) 45 (15%)
Multifocality 0 1
 Unifocal 107 (35%) 107 (35%)
 Multifocal 44 (15%) 44 (15%)
 Tumor stage 0.333 <0.0001
 Ta–T1 129 (43%) 83 (27%)
 T2–T4 22 (7%) 68 (23%)
Nodal metastasis 0.207 <0.0001
 N0 150 (50%) 136 (45%)
 N1–N2 1 (0%) 15 (5%)
Histological grade 0.315 <0.0001
 Low 111 (37%) 64 (21%)
 High 40 (13%) 87 (29%)

Abbreviations: UCB, urothelial cell carcinoma of the bladder; CD204+ST Mφ, CD204+ Mφ in stromal regions.

Significant P-values are shown in bold font.